One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Osteoporosis: overlooked in men for too long
doi : 10.1016/S2213-8587(20)30408-3
Volume 9, Issue 1, January 2021, Page 1
Coronavirus vaccine? Join the queue
doi : 10.1016/S2213-8587(20)30409-5
Volume 9, Issue 1, January 2021, Page 1
Phaeochromocytoma and pregnancy: looking towards better outcomes, less fear, and valuable recommendations
Karel Pacak, David Taieb
doi : 10.1016/S2213-8587(20)30371-5
Volume 9, Issue 1, January 2021, Pages 2-3
SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond
Katherine R Tuttle
doi : 10.1016/S2213-8587(20)30374-0
Volume 9, Issue 1, January 2021, Pages 3-5
Testosterone replacement to prevent type 2 diabetes? Not just yet
Naveed Sattar, James G Boyle, Ebaa Al-Ozairi
doi : 10.1016/S2213-8587(20)30373-9
Volume 9, Issue 1, January 2021, Pages 5-6
Global 30-day outcomes after bariatric surgery during the COVID-19 pandemic (GENEVA): an international cohort study
Rishi Singhal, Abd A Tahrani, Christian Ludwig, Kamal Mahawar, ... Y van der Burgh
doi : 10.1016/S2213-8587(20)30375-2
Volume 9, Issue 1, January 2021, Pages 7-9
Skin-whitening creams: worth the risk?
Talha Burki
doi : 10.1016/S2213-8587(20)30400-9
Volume 9, Issue 1, January 2021, Page 10
Thyroid cancer in the USA: current trends and outstanding questions
Louise Davies, Jenny K Hoang
doi : 10.1016/S2213-8587(20)30372-7
Volume 9, Issue 1, January 2021, Pages 11-12
Correction to Lancet Diabetes Endocrinol 2021; 9: 46–52
doi : 10.1016/S2213-8587(20)30407-1
Volume 9, Issue 1, January 2021, Page e1
Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature
Irina Bancos, Elizabeth Atkinson, Charis Eng, William F Young, ... Natalia V Khudiakova
doi : 10.1016/S2213-8587(20)30363-6
Volume 9, Issue 1, January 2021, Pages 13-21
Phaeochromocytoma or paraganglioma (collectively known as PPGL) in pregnant women can lead to severe complications and death due to associated catecholamine excess. We aimed to identify factors associated with maternal and fetal outcomes in women with PPGL during pregnancy.
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
David C Wheeler, Bergur V Stef?nsson, Niels Jongs, Glenn M Chertow, ... Hiddo J L Heerspink
doi : 10.1016/S2213-8587(20)30369-7
Volume 9, Issue 1, January 2021, Pages 22-31
Dapagliflozin reduces the risk of kidney failure and heart failure in patients with chronic kidney disease. We aimed to investigate the effects of dapagliflozin on kidney, cardiovascular, and mortality outcomes according to presence or absence of type 2 diabetes and according to underlying cause of chronic kidney disease, reported as diabetic nephropathy, chronic glomerulonephritides, ischaemic or hypertensive chronic kidney disease, or chronic kidney disease of other or unknown cause.
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial
Gary Wittert, Karen Bracken, Kristy P Robledo, Mathis Grossmann, ... Anthony Keech
doi : 10.1016/S2213-8587(20)30367-3
Volume 9, Issue 1, January 2021, Pages 32-45
Men who are overweight or obese frequently have low serum testosterone concentrations, which are associated with increased risk of type 2 diabetes. We aimed to determine whether testosterone treatment prevents progression to or reverses early type 2 diabetes, beyond the effects of a community-based lifestyle programme.
Guideline recommendations and the positioning of newer drugs in type 2 diabetes care
Nikolaus Marx, Melanie J Davies, Peter J Grant, Chantal Mathieu, ... John B Buse
doi : 10.1016/S2213-8587(20)30343-0
Volume 9, Issue 1, January 2021, Pages 46-52
